Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma.
about
Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Classical Hodgkin lymphoma pri ...... diffuse large B-cell lymphoma.
@en
Classical Hodgkin lymphoma pri ...... diffuse large B-cell lymphoma.
@nl
type
label
Classical Hodgkin lymphoma pri ...... diffuse large B-cell lymphoma.
@en
Classical Hodgkin lymphoma pri ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Classical Hodgkin lymphoma pri ...... diffuse large B-cell lymphoma.
@en
Classical Hodgkin lymphoma pri ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P1476
Classical Hodgkin lymphoma pri ...... diffuse large B-cell lymphoma.
@en
P2093
Akiko Miyagi Maeshima
Dai Maruyama
Hideaki Kitahara
Hirokazu Taniguchi
Kensei Tobinai
Suguru Fukuhara
Tatsuya Suzuki
Wataru Munakata
P2860
P2888
P304
P356
10.1007/S12185-016-2018-Y
P577
2016-05-12T00:00:00Z